Nocion Therapeutics

Nocion Therapeutics

Developing positively charged versions of “caines” -- broadly acting intracellular sodium channel blockers

Nocion Therapeutics company information

Edit
Growth stage
  • Edit
Are you an employee or an investor of this company?
Add your profile